COLL Collegium Pharmaceutical, Inc.

25.21USD-2.78%Mkt Cap: 783.41M USDP/E: 23.13

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system …

Institutional holders20 on file

Key Statistics

Company
Market Cap783.41M USD
Enterprise Value1.87B USD
Revenue (TTM)815.19M USD
Gross Profit463.26M USD
Net Income (TTM)62.87M USD
Revenue/Share25.49 USD
Last Price25.21 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees423
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)23.13
P/E (Forward)3.56
PEG0.76
EV/EBITDA4.45
EV/Revenue2.29
P/S0.96
P/B2.64
EPS (TTM)1.09 USD
EPS (Forward)7.08 USD
52W Range
21.4313% of range50.79
52W High50.79 USD
52W Low21.43 USD
Profitability
Gross Margin59.35%
Oper. Margin22.90%
EBITDA Margin51.48%
Profit Margin8.05%
ROE20.84%
ROA3.79%
ROIC16.60%
ROCE14.67%
Growth
Revenue Growth3.30%
Earnings Growth-29.00%
Cash Flow & Leverage
Operating CF329.32M USD
CapEx (TTM)1.74M USD
FCF Margin45.02%
FCF Yield46.84%
Net Debt1.06B USD
Net Debt/EBITDA2.53
Net Debt/FCF2.90
Balance Sheet
Debt/Equity2.70
Current Ratio1.01
Quick Ratio0.76
Book Value/Sh9.54 USD
Cash/Share4.66 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)44.00 USD
Upside (mean)+74.5%
Target Range28.00 USD – 60.00 USD
28.00+74.5% to mean60.00
# Analysts8
Ownership
Shares Out.31.08M
Float28.29M
Insiders1.21%
Institutions124.13%
Short Interest
Short Ratio7.8d
Short % Float20.16%
Short % Out.16.72%
Shares Short5.19M
Short (prev mo.)5.52M
Technical
SMA 5023.07 (+9.3%)
SMA 20032.05 (-21.3%)
Beta0.73
S&P 52W Chg12.08%
Avg Vol (30d)627.56K
Avg Vol (10d)702.78K
Technical Indicators
RSI (14)58.5
MACD0.5747
MACD Signal0.4320
MACD Hist.+0.1427
BB Upper26.20 USD
BB Middle24.35 USD
BB Lower22.51 USD
BB Width15.16%
ATR (14)0.9253 USD
Vol Ratio (20d)0.72x

About Collegium Pharmaceutical (NASDAQ: COLL)

›

Collegium Pharmaceutical (NASDAQ: COLL) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 423 employees.

The shares were at 25.21 USD on 19 November 2026, down 38.0% over 52 weeks. Its 52-week range is 21.43 USD to 50.79 USD: the price is 50.4% below the high and 17.6% above the low.

At a market capitalisation of 783.41M USD, it trades at 23.1 times trailing earnings and 3.6 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, so COLL is valued in line with them.

Collegium Pharmaceutical reports return on equity of 20.8%, an operating margin of 22.9% and revenue up 3.3% year over year.

Its debt exceeds its cash by 1.06B USD, a debt-to-equity ratio of 2.70. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 8 analysts cover the stock, with an average rating of Buy; their mean price target of 44.00 USD is 74.5% above the current price. The next earnings report is expected on 25 February 2027.